A bone densitometer also known as a dual-energy x-ray absorptiometry (DXA) machine is a device that is used to measure the bone mass and mineral content of a particular part of the skeleton by determining the rate at which it absorbs ionizing radiation. DXA is a simple, quick, and noninvasive technique.
The Bone Densitometer Market is expected to grow at a rate of 4.5% by 2026. The rising occurrence of osteoporosis incidence and vitamin D deficiency, the increasing geriatric population, technological advancements in the field of bone densitometry, growing incidents of fragility fracture, and an increasing number of bone-related disorders are some of the key factors driving the global bone densitometer market. However, the high cost associated with bone densitometer products is expected to restrain the market growth.
Increased Adoption of Dual-Energy X-ray Absorptiometry (DEXA) In Various Applications Drives the Bone Densitometer Market
DEXA is a fast and reliable technique of choice in the diagnosis and monitoring of osteoporosis since it objectively measures the most relevant parameters. It is also useful for measuring body composition and its distribution by region. In recent years, new applications have been developed which include vertebral morphometry through the study of the lateral spine, prosthesis integration in orthopedics, and lipodystrophy and lipoatrophy in HIV+ patients. Also, DEXA is comparatively inexpensive with notably shorter scan times and radiation exposure compared to other imaging options.
Estimation of Bone Mineral Density (BMS) Amongst Postmenopausal Women Fuels the Bone Densitometer Market Demand
Osteoporosis is more prevalent among postmenopausal women. This is because the low level of estrogen hormone that occurs at the time of menopause results in significant bone loss. Various researches have demonstrated that there is up to a 10% loss in bone mass in the first five years of women after attaining the menopause phase. It is considered the gold standard for diagnosing osteoporosis and expecting fracture risk with algorithms like the Fracture Risk Assessment Tool.
Adoption of Quantitative Ultrasound (QUS) For Estimating Bone Mineral Status in Children Boosts the Market
QUS is a comparatively recent and noninvasive method of estimating bone mineral status in the peripheral skeleton. In addition to bone density, QUS methods provide some structural information, which may be important in determining fracture risk. QUS technique is safe, easy to use, and cost-effective. The devices are portable, only a few minutes are needed to perform the measurements, and it is radiation-free. These characteristics of QUS are particularly indicated to assess bone mineral status in children.
Explore Premium Report on Bone Densitometer Market @ https://meditechinsights.com/bone-densitometer-market/
North America Holds the Major Share of the Bone Densitometer Market
North America holds the largest share of the bone densitometer market, followed by Europe and APAC. The large share of North America can be attributed to the rising prevalence of osteoporosis, a well-developed healthcare infrastructure, technological advancements in bone densitometer products, and the presence of key market players in the region.
Companies Adopting Organic & Inorganic Growth Strategies to Increase their Market Share
Key players operating in bone densitometer market are adopting various business strategies such as collaborations, acquisitions, partnerships, and new product launches to garner market share. For instance,
â€¢In February 2022, Echolight Medical and Aurora Spine Corporation entered into a joint co-marketing agreement. The mutual agreement is likely to help Aurora to combine Echolightâ€™s bone health assessment capabilities with its proprietary DEXA Technology-based patient-matched implants and promote Echolightâ€™s devices
â€¢In July 2021, DMS Imaging announced the extension of its white-label manufacturing contract for the FUJIFILM Healthcare Group
Competitive Landscape Analysis of Bone Densitometer Market
Some of the key players operating in the global bone densitometer market include GE Healthcare, Hologic Inc., BeamMed Ltd., Echolight S.P.A, Scanflex Healthcare AB, and Medonica Co. Ltd, among others.
For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
Associate, Medi-Tech Insights
+32 498 86 80 79